Krishnamurthy Venkataramu N, Eliason Jonathan L, Henke Peter K, Rectenwald John E
Section of Vascular and Interventional Radiology, Ann Arbor VA Health System, Ann Arbor, MI 48109-5030, USA.
Ann Vasc Surg. 2010 May;24(4):487-97. doi: 10.1016/j.avsg.2009.12.002. Epub 2010 Apr 2.
Endovascular revascularization of chronic total occlusion (CTO) of the iliac arteries is rapidly becoming first-line treatment, with surgical aortofemoral bypass procedures reserved for failure of endovascular treatment. Percutaneous subintimal recanalization is the most common endovascular revascularization technique for CTO of the iliac arteries. The primary reason for failure of the subintimal recanalization technique is failure to reenter the true lumen. This report describes the benefits of using true lumen reentry devices to improve the success and safety of conventional subintimal recanalization for revascularization of CTO of the iliac arteries.
This is a retrospective review of 11 patients with CTO of the iliac arteries in whom true lumen reentry was not successful using conventional subintimal recanalization. An intravascular ultrasound (IVUS)-guided true lumen reentry device was used in all patients to assist true lumen reentry. Clinical records, procedural records, angiographic imaging, and follow-up data were analyzed. Indications for intervention, length and location of the lesion treated, access site(s), location of true lumen reentry, stent use, procedural times, technical success, and complications were analyzed in all patients.
The technical success of true lumen reentry at the desired point was 100%. Total procedure time from the start of reentry device manipulation to achieve reentry was <10 min (routinely <5 min). Mean patient follow-up was 10.5 months. At follow-up, all patients had palpable femoral pulses. The ankle-brachial index normalized (>0.9) in six patients and improved significantly in the remaining five patients. Rest pain resolved and claudication improved in all patients. Out of seven patients who had foot ulcers, the ulcers healed completely in five and demonstrated improved healing in two, with the clinical manifestation of osteomyelitis resolved in two. No procedure-related complications were noted. The amputation-free survival was 100%.
True lumen reentry devices greatly improve the technical success and safety of percutaneous recanalization procedures in CTO of the iliac arteries. There are significant reductions in procedure time and complication rates associated with the use of these devices.
髂动脉慢性完全闭塞(CTO)的血管腔内血运重建正迅速成为一线治疗方法,而手术主动脉股动脉旁路移植术则留作血管腔内治疗失败后的选择。经皮内膜下再通术是髂动脉CTO最常见的血管腔内血运重建技术。内膜下再通技术失败的主要原因是未能重新进入真腔。本报告描述了使用真腔再入装置改善传统内膜下再通术治疗髂动脉CTO血运重建成功率和安全性的益处。
这是一项对11例髂动脉CTO患者的回顾性研究,这些患者使用传统内膜下再通术未能成功实现真腔再入。所有患者均使用血管内超声(IVUS)引导的真腔再入装置辅助真腔再入。分析临床记录、手术记录、血管造影成像和随访数据。分析所有患者的干预指征、治疗病变的长度和位置、入路部位、真腔再入位置、支架使用情况、手术时间、技术成功率和并发症。
在期望点实现真腔再入的技术成功率为100%。从开始操作再入装置到实现再入的总手术时间<10分钟(通常<5分钟)。患者平均随访时间为10.5个月。随访时,所有患者股动脉均可触及搏动。6例患者的踝肱指数恢复正常(>0.9),其余5例患者明显改善。所有患者的静息痛均缓解,跛行改善。7例足部溃疡患者中,5例溃疡完全愈合,2例愈合情况改善,2例骨髓炎临床表现消失。未发现与手术相关的并发症。无截肢生存率为100%。
真腔再入装置大大提高了髂动脉CTO经皮再通手术的技术成功率和安全性。使用这些装置可显著缩短手术时间并降低并发症发生率。